+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Eye Allergy Therapeutics Market 2019-2023 - Product Image

Global Eye Allergy Therapeutics Market 2019-2023

  • ID: 4772966
  • Report
  • Region: Global
  • 140 pages
  • TechNavio
UP TO OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Akorn Inc.
  • Allergan Plc
  • Novartis AG
  • MORE
The global eye allergy therapeutics market is currently witnessing a high unmet medical need for a once-daily double-action eye preparation for the treatment of various types of eye allergies. At present, the drugs administered for eye allergies are intended to treat symptoms such as redness and itching, and they provide substantial assistance to patients leaving approximately 20-30% of the patients untreated. Also, the side effects associated with the available therapeutic options limit their use for a long duration. Therefore, the market is currently exhibiting a need for effective multiple-dose therapies that can treat the signs and symptoms of eye allergies with a quick onset of action and without side effects. This is expected to propel the growth of the market during the forecast period. Analysts have predicted that the eye allergy therapeutics market will register a CAGR of almost 5% by 2023.

Market Overview

Significant comorbidity associated with eye allergies

All types of eye allergies are associated with chronic symptoms such as ocular itching inflammation redness and watery eyes, which are persistently disturbing, having an adverse effect on patients' life. This leads to loss of work performance decreased productivity and increased healthcare costs, which can put a significant economic burden on patients. To avoid the substantial comorbidity associated with eye allergies, people spend on the required therapeutics, which will drive the growth of the market during the forecast period.

Lack of awareness

The level of awareness about eye allergies is generally low. Media and the Internet were the primary sources of information for most people. The level of knowledge and awareness regarding eye allergies are low among medical students and was far lower among those with a non-medical background. The lack of awareness of the symptoms associated with eye allergies and the negligence in seeking medical help for their treatment are expected to limit the growth of the market during the forecast period.

Competitive Landscape

The market appears to be fragmented. The presence of several companies, including Akorn Inc. and Allergan Plc, the competitive environment is quite intense. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies. Bausch Health Companies Inc., Novartis AG, and Santen Pharmaceutical Co. Ltd. are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Akorn Inc.
  • Allergan Plc
  • Novartis AG
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: EYE ALLERGY: AN OVERVIEW

PART 07: PIPELINE ANALYSIS

PART 08: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Antihistamines - Market size and forecast 2018-2023
  • Mast cell stabilizers - Market size and forecast 2018-2023
  • Corticosteroids - Market size and forecast 2018-2023
  • Immunomodulators - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product
PART 09: CUSTOMER LANDSCAPE

PART 10: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 15: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Akorn Inc.
  • Allergan Plc
  • Bausch Health Companies Inc.
  • Novartis AG
  • Santen Pharmaceutical Co. Ltd.
PART 16: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
PART 17: EXPLORE

List of Exhibits:
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Facts about eye allergy
Exhibit 18: Pathophysiology of eye allergy
Exhibit 19: Pipeline landscape
Exhibit 20: Some key clinical trials: Eye allergy therapeutics
Exhibit 21: Product - Market share 2018-2023 (%)
Exhibit 22: Comparison by product
Exhibit 23: Antihistamines - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Classification of antihistamines.
Exhibit 25: Example of antihistamine ophthalmic drops
Exhibit 26: Antihistamines - Year-over-year growth 2019-2023 (%)
Exhibit 27: Mast cell stabilizers - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Examples of mast cell stabilizer ophthalmic drops
Exhibit 29: Mast cell stabilizers - Year-over-year growth 2019-2023 (%)
Exhibit 30: Corticosteroids - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Examples of corticosteroid ophthalmic drops
Exhibit 32: Side effects of corticosteroid ophthalmic drops
Exhibit 33: Corticosteroids - Year-over-year growth 2019-2023 (%)
Exhibit 34: Immunomodulators - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Examples of immunosuppressant ophthalmic drops
Exhibit 36: Immunomodulators - Year-over-year growth 2019-2023 (%)
Exhibit 37: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Examples of decongestant ophthalmic drops
Exhibit 39: Example of NSAID ophthalmic drops
Exhibit 40: Examples of artificial tears
Exhibit 41: Others - Year-over-year growth 2019-2023 (%)
Exhibit 42: Market opportunity by product
Exhibit 43: Customer landscape
Exhibit 44: Market share by geography 2018-2023 (%)
Exhibit 45: Geographic comparison
Exhibit 46: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 47: ALLEVIATE trial in allergic conjunctivitis patients
Exhibit 48: North America - Year-over-year growth 2019-2023 (%)
Exhibit 49: Top 3 countries in North America
Exhibit 50: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 51: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 52: Top 3 countries in Europe
Exhibit 53: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 54: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 55: Top 3 countries in Asia
Exhibit 56: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 57: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 58: Top 3 countries in ROW
Exhibit 59: Key leading countries
Exhibit 60: Market opportunity
Exhibit 61: Impact of allergy symptoms on professional and personal lives of patients
Exhibit 62: Pharmacologic treatment for allergic conjunctivitis
Exhibit 63: Impact of drivers and challenges
Exhibit 64: Benefits associated with SCIT
Exhibit 65: Risk factors that increase susceptibility to eye allergies
Exhibit 66: Vendor landscape
Exhibit 67: Landscape disruption
Exhibit 68: Vendors covered
Exhibit 69: Vendor classification
Exhibit 70: Market positioning of vendors
Exhibit 71: Akorn Inc. - Vendor overview
Exhibit 72: Akorn Inc. - Business segments
Exhibit 73: Akorn Inc. - Organizational developments
Exhibit 74: Akorn Inc. - Segment focus
Exhibit 75: Akorn Inc. - Key offerings
Exhibit 76: Akorn Inc. - Key customers
Exhibit 77: Allergan Plc - Vendor overview
Exhibit 78: Allergan Plc - Business segments
Exhibit 79: Allergan Plc - Organizational developments
Exhibit 80: Allergan Plc - Geographic focus
Exhibit 81: Allergan Plc - Segment focus
Exhibit 82: Allergan Plc - Key offerings
Exhibit 83: Allergan Plc - Key customers
Exhibit 84: Bausch Health Companies Inc. - Vendor overview
Exhibit 85: Bausch Health Companies Inc. - Business segments
Exhibit 86: Bausch Health Companies Inc. - Organizational developments
Exhibit 87: Bausch Health Companies Inc. - Geographic focus
Exhibit 88: Bausch Health Companies Inc. - Segment focus
Exhibit 89: Bausch Health Companies Inc. - Key offerings
Exhibit 90: Bausch Health Companies Inc. - Key customers
Exhibit 91: Novartis AG - Vendor overview
Exhibit 92: Novartis AG - Business segments
Exhibit 93: Novartis AG - Organizational developments
Exhibit 94: Novartis AG - Geographic focus
Exhibit 95: Novartis AG - Segment focus
Exhibit 96: Novartis AG - Key offerings
Exhibit 97: Novartis AG - Key customers
Exhibit 98: Santen Pharmaceutical Co. Ltd. - Vendor overview
Exhibit 99: Santen Pharmaceutical Co. Ltd. - Business segments
Exhibit 100: Santen Pharmaceutical Co. Ltd. - Organizational developments
Exhibit 101: Santen Pharmaceutical Co. Ltd. - Geographic focus
Exhibit 102: Santen Pharmaceutical Co. Ltd. - Segment focus
Exhibit 103: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibit 104: Santen Pharmaceutical Co. Ltd. - Key customers
Exhibit 105: Validation techniques employed for market sizing
Exhibit 106: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Akorn Inc.
  • Allergan Plc
  • Novartis AG
  • MORE
The analyst recognizes the following companies as the key players in the global eye allergy therapeutics market: Akorn Inc., Allergan Plc, Bausch Health Companies Inc., Novartis AG, and Santen Pharmaceutical Co. Ltd.

Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is the increasing air pollution leading to various health hazards, including eye allergies.”

According to the report, one of the major drivers for this market is the rising prevalence of eye allergies.

Further, the report states that one of the major factors hindering the growth of this market is the lack of awareness.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Akorn Inc.
  • Allergan Plc
  • Bausch Health Companies Inc.
  • Novartis AG
  • Santen Pharmaceutical Co. Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll